Cargando…
Formulation and Evaluation of Rizatriptan Benzoate Mouth Disintegrating Tablets
The present investigation deals with development of mouth disintegrating tablets of rizatriptan benzoate to produce the intended benefits. Mouth disintegrating tablets of rizatriptan benzoate were prepared using superdisintegrants crospovidone, carboxymethylcellulose calcium, Indion 414 and Indion 2...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883231/ https://www.ncbi.nlm.nih.gov/pubmed/20582194 http://dx.doi.org/10.4103/0250-474X.62253 |
_version_ | 1782182248802418688 |
---|---|
author | Keny, R. V. Desouza, Chrisma Lourenco, C. F. |
author_facet | Keny, R. V. Desouza, Chrisma Lourenco, C. F. |
author_sort | Keny, R. V. |
collection | PubMed |
description | The present investigation deals with development of mouth disintegrating tablets of rizatriptan benzoate to produce the intended benefits. Mouth disintegrating tablets of rizatriptan benzoate were prepared using superdisintegrants crospovidone, carboxymethylcellulose calcium, Indion 414 and Indion 234 using the direct compression method. The tablets prepared were evaluated for thickness, uniformity of weight, content uniformity, hardness, friability, wetting time, in vitro and in vivo disintegration time, mouth feel, in vitro drug release and assay by high performance liquid chromatography. The tablets disintegrated in vitro and in vivo within 4 to 7 s and 6 to 19 s, respectively. Almost 90% of drug was released from all formulations within 20 min. The drug release from the formulations followed first order kinetics. Stability studies of the tablets at 40±2°/75%±5% RH for 1 mo showed non significant drug loss. The formulation containing combination of crospovidone and Indion 234 was found to give the best results. Apart from fulfilling all official and other specifications, the tablets exhibited higher rate of release. |
format | Text |
id | pubmed-2883231 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Medknow Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-28832312010-06-25 Formulation and Evaluation of Rizatriptan Benzoate Mouth Disintegrating Tablets Keny, R. V. Desouza, Chrisma Lourenco, C. F. Indian J Pharm Sci Research Paper The present investigation deals with development of mouth disintegrating tablets of rizatriptan benzoate to produce the intended benefits. Mouth disintegrating tablets of rizatriptan benzoate were prepared using superdisintegrants crospovidone, carboxymethylcellulose calcium, Indion 414 and Indion 234 using the direct compression method. The tablets prepared were evaluated for thickness, uniformity of weight, content uniformity, hardness, friability, wetting time, in vitro and in vivo disintegration time, mouth feel, in vitro drug release and assay by high performance liquid chromatography. The tablets disintegrated in vitro and in vivo within 4 to 7 s and 6 to 19 s, respectively. Almost 90% of drug was released from all formulations within 20 min. The drug release from the formulations followed first order kinetics. Stability studies of the tablets at 40±2°/75%±5% RH for 1 mo showed non significant drug loss. The formulation containing combination of crospovidone and Indion 234 was found to give the best results. Apart from fulfilling all official and other specifications, the tablets exhibited higher rate of release. Medknow Publications 2010 /pmc/articles/PMC2883231/ /pubmed/20582194 http://dx.doi.org/10.4103/0250-474X.62253 Text en © Indian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Paper Keny, R. V. Desouza, Chrisma Lourenco, C. F. Formulation and Evaluation of Rizatriptan Benzoate Mouth Disintegrating Tablets |
title | Formulation and Evaluation of Rizatriptan Benzoate Mouth Disintegrating Tablets |
title_full | Formulation and Evaluation of Rizatriptan Benzoate Mouth Disintegrating Tablets |
title_fullStr | Formulation and Evaluation of Rizatriptan Benzoate Mouth Disintegrating Tablets |
title_full_unstemmed | Formulation and Evaluation of Rizatriptan Benzoate Mouth Disintegrating Tablets |
title_short | Formulation and Evaluation of Rizatriptan Benzoate Mouth Disintegrating Tablets |
title_sort | formulation and evaluation of rizatriptan benzoate mouth disintegrating tablets |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883231/ https://www.ncbi.nlm.nih.gov/pubmed/20582194 http://dx.doi.org/10.4103/0250-474X.62253 |
work_keys_str_mv | AT kenyrv formulationandevaluationofrizatriptanbenzoatemouthdisintegratingtablets AT desouzachrisma formulationandevaluationofrizatriptanbenzoatemouthdisintegratingtablets AT lourencocf formulationandevaluationofrizatriptanbenzoatemouthdisintegratingtablets |